Novanta (NOVT.U) Stock Overview

Provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. More details

NOVT.U fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	3/6
Past Performance	1/6
Financial Health	3/6
Dividends	0/6

Rewards

Earnings are forecast to grow 43.24% per year

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Large one-off items impacting financial results

NOVT.U Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Novanta Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Novanta
Historical stock prices
Current Share Price	US$49.88
52 Week High	US$52.00
52 Week Low	US$47.57
Beta	1.59
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	3.70%

Recent updates

Shareholder Returns

	NOVT.U	US Electronic	US Market
7D	0.9%	-3.2%	-2.0%
1Y	n/a	28.4%	9.4%

Return vs Industry: Insufficient data to determine how NOVT.U performed against the US Electronic industry.

Return vs Market: Insufficient data to determine how NOVT.U performed against the US Market.

Price Volatility

Is NOVT.U's price volatile compared to industry and market?
NOVT.U volatility
NOVT.U Average Weekly Movement	n/a
Electronic Industry Average Movement	7.6%
Market Average Movement	6.5%
10% most volatile stocks in US Market	17.1%
10% least volatile stocks in US Market	2.9%

Stable Share Price: NOVT.U's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine NOVT.U's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1968	3,000	Matthijs Glastra	www.novanta.com

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles.

Novanta Inc. Fundamentals Summary

How do Novanta's earnings and revenue compare to its market cap?
NOVT.U fundamental statistics
Market cap	US$3.81b
Earnings (TTM)	US$52.82m
Revenue (TTM)	US$960.31m

72.1x

P/E Ratio

4.0x

P/S Ratio

Is NOVT.U overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NOVT.U income statement (TTM)
Revenue	US$960.31m
Cost of Revenue	US$527.29m
Gross Profit	US$433.02m
Other Expenses	US$380.20m
Earnings	US$52.82m

Last Reported Earnings

Sep 26, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	1.48
Gross Margin	45.09%
Net Profit Margin	5.50%
Debt/Equity Ratio	56.3%

How did NOVT.U perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/11/23 01:55
End of Day Share Price	2025/11/21 00:00
Earnings	2025/09/26
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Novanta Inc. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Robert Mason	Baird
Andrew Buscaglia	Berenberg
Lee Jagoda	CJS Securities, Inc.

Novanta Inc.NasdaqGS:NOVT.U Stock Report